Greenwich Lifesciences Inc (GLSI) Annual Balance Sheets

Annual · GAAP · USD millions
Access GLSI quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Greenwich Lifesciences Inc finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent6.18
Cash & Short-term Investments6.00
Total Current Assets6.18
Intangible Assets0.00
Tax Assets, Noncurrent9.28
Total Assets6.18
Liabilities
Accounts Payable and Accrued Liabilities, Current LI4.87
Employee-related Liabilities, Current AC0.28
Other Liabilities, Current0.00
Deferred Compensation Liability, Current LI0.00
Total Current Liabilities5.82
Total Long-term Debt0.00
Deferred Compensation Liability, Current and Noncurrent LI0.67
Total Liabilities5.82
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock87.48
Retained Earnings / Accumulated Deficit-87.14
Defined Benefit Plan and Other0.00
Other Equity0.00
Common Stockholder's Equity0.35
Total Stockholder's Equity0.35
Liabilities & Stockholder's Equity6.18
4 historic quarters locked

Sign in to unlock the full Greenwich Lifesciences Inc balance sheet history.

About Greenwich Lifesciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: June 1, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-026651

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.